Table 16 Correlation coefficient R values for properties of PCOS drugs.

From: Ranking polycystic ovarian syndrome (PCOS) drugs using degree-based indices in QSPR models and CRITIC-driven MCDM methods

Indices

MW

BP

E

MR

P

MV

ACD/logP

M1(G)

0.7924

0.7521

0.8182

0.8049

0.805

0.7457

0.555

M2(G)

0.7415

0.7101

0.7942

0.7537

0.754

0.6821

0.4827

mM2(G)

0.8658

0.7482

0.7403

0.8383

0.838

0.8198

0.76

ReZG3(G)

0.6153

0.5865

0.6988

0.6227

0.6231

0.5587

0.3733

F(G)

0.6817

0.6446

0.7408

0.6863

0.6867

0.6251

0.4329

I(G)

0.8655

0.8393

0.8843

0.8817

0.882

0.8049

0.6125

H(G)

0.9695

0.9089

0.8608

0.9783

0.9784

0.9562

0.783

SDD(G)

0.7566

0.6918

0.7628

0.754

0.754

0.7247

0.54

B1(G)

0.7775

0.7098

0.7956

0.7715

0.7718

0.7327

0.4882

B2(G)

0.6412

0.5792

0.6969

0.6379

0.6384

0.5909

0.3816

mB1(G)

0.9322

0.9082

0.8519

0.9186

0.9186

0.8928

0.7032

mB2(G)

0.7566

0.706

0.6303

0.721

0.7206

0.735

0.6586